○Shinobu Sakai¹, Reiko Adachi¹, Maiko Tahara¹, Reiko Teshima², Junko Komura³, Yoshiaki Ikarashi¹ (1. National Institute of Health Sciences, 2. Okayama University of Science, 3. Setsunan University)

○Yuusuke Oohashi¹, Kiyohito Noda¹, Yumiko Nomura¹, Mayumi Shikano¹, Nobuhiko Okabe² (1. Tokyo Univ. of Science Pharm, 2. Kawasaki City Institute for Public Health)

○Kiyohito Noda¹, Yuusuke Oohashi¹, Yumiko Nomura¹, Mayumi Shikano¹, Nobuhiko Okabe² (1. Tokyo Univ. of Science Pharm, 2. Kawasaki City Institute for Public Health)

○Kazuma Ishimoto¹, Keisuke Tachibana^1,2, Toshikatsu Washio³, Tatsuhiko Arafune⁴, Masuo Kondoh^1,2 (1. Sch Pharm Sci., Osaka Univ., 2. Grad Sch Pharm Sci., Osaka Univ., 3. Health Research Institute, AIST, 4. Sch Sci Eng., Tokyo Denki Univ.)

○Makiko Sho¹, Keisuke Tachibana², Jun Kunisawa^3,4,5,6, Masuo Kondoh² (1. Sch. Pharm. Sci., Osaka Univ., 2. Grad. Sch. Pharm. Sci., Osaka Univ., 3. Lab Vaccine Materials, National Institute of Biomedical Innovation, 4. Grad. Sch. Med. Pharm Sci. Dent., Osaka Univ., 5. Grad. Sch. Med., Kobe Univ., 6. Inst. Med. Sci., Univ. Tokyo)

○Mika Kiyama¹, Naoko Yoshida², Hirohito Tsuboi², Yoshio Akimoto³, Kazuko Kimura³, Kazuo Ohyanagi¹ (1. Faculty of Pharm. Sci., Hokuriku Univ., 2. Faculty of Pharm., Kanazawa Univ., 3. Grad. Sch. Med. Sci., Kanazawa Univ.)